Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Deans & Lyons LLP
DALLAS, Jan. 17, 2014 /PRNewswire/ -- Securities lawyers at Deans & Lyons announce an investigation of the board of Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR). Concerned AEGR investors who purchased between April 30, 2013 and January 9, 2014 are encouraged to contact securities attorney Hamilton Lindley at 877-819-8033 or firstname.lastname@example.org about their rights and remedies.
"Because Aegerion's stock fell 14.58% after an announcement on January 9, 2014 that the company received a subpoena from the U.S. Department of Justice regarding statements made on CNBC, this potential investigation is concerned with whether operations are affecting stock value for Aegerion Pharmaceuticals, Inc.," said securities lawyer Hamilton Lindley. "Our potential investigation will seek to ensure that all relevant information is disclosed about the operations of Aegerion Pharmaceuticals, Inc."
Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide. AEGR stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at email@example.com or 877-819-8033 with questions or concerns.
©2012 PR Newswire. All Rights Reserved.